🇺🇸 FDA
Patent

US 11230590

Hyperimmunized egg product for treatment of necrotic enteritis in poultry

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 11230590 (Hyperimmunized egg product for treatment of necrotic enteritis in poultry) held by United States of America as represented by the Secretary of the Air Force expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K47/46, A61K9/0056